Security key
046513206
Atara Biotherapeutics, Inc. - Common Stock (ATRA)
CUSIP: 046513206
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 8,191,888
- Total 13F shares
- 2,368,286
- Share change
- -48,051
- Total reported value
- $31,519,295
- Price per share
- $13.31
- Number of holders
- 41
- Value change
- -$410,987
- Number of buys
- 19
- Number of sells
- 14
Report period
Q4 2024
Institutions
41
Top holders
10
ATRA full security history
Newer quarter: Q1 2025
Previous quarter: Q3 2024
Atara Biotherapeutics, Inc. SEC filings
Atara Biotherapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 046513206
Recent filing periods:
Top shareholders of ATRA - Atara Biotherapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| EcoR1 Capital, LLC |
13F
|
Company |
5.7%
|
468,938
|
$3,812,466 | — | 30 Sep 2024 | |
| Redmile Group, LLC |
13F
|
Company |
5.5%
|
452,270
|
$3,676,955 | — | 30 Sep 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
3.2%
|
260,480
|
$2,117,702 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
2.5%
|
203,627
|
$1,655,488 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.2%
|
180,715
|
$1,469,213 | — | 30 Sep 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
2.1%
|
176,053
|
$1,431,311 | — | 30 Sep 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
1.6%
|
129,144
|
$1,049,000 | — | 30 Sep 2024 | |
| Vestal Point Capital, LP |
13F
|
Company |
1.5%
|
124,677
|
$1,013,624 | — | 30 Sep 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.92%
|
75,196
|
$611,343 | — | 30 Sep 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.83%
|
67,734
|
$550,677 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
0.74%
|
60,954
|
$495,556 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.57%
|
46,720
|
$379,916 | — | 30 Sep 2024 | |
| Centiva Capital, LP |
13F
|
Company |
0.53%
|
43,403
|
$352,866 | — | 30 Sep 2024 | |
| STALEY CAPITAL ADVISERS INC |
13F
|
Company |
0.49%
|
40,000
|
$325,200 | — | 30 Sep 2024 | |
| Eric Dobmeier |
3/4/5
|
Director |
—
mixed-class rows
|
642,825
mixed-class rows
|
$219,133 | — | 10 Nov 2023 | |
| FMR LLC |
13F
|
Company |
0.31%
|
25,061
|
$203,746 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.27%
|
22,353
|
$181,730 | — | 30 Sep 2024 | |
| Amar Murugan |
3/4/5
|
EVP, Chief Legal Officer |
—
class O/S missing
|
26,827
|
$177,890 | — | 16 Aug 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.2%
|
16,189
|
$131,616 | — | 30 Sep 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.17%
|
14,000
|
$113,820 | — | 30 Sep 2024 | |
| Jakob Dupont |
3/4/5
|
EVP, Head of R&D |
—
mixed-class rows
|
608,781
mixed-class rows
|
$113,119 | — | 02 Mar 2023 | |
| Charlene A. Banard |
3/4/5
|
EVP, Chief Technical Officer |
—
class O/S missing
|
276,010
|
$107,368 | — | 16 May 2023 | |
| Utpal Koppikar |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
181,978
|
$70,789 | — | 02 Mar 2023 | |
| Kristin Yarema |
3/4/5
|
Chief Commercial Officer |
—
mixed-class rows
|
257,007
mixed-class rows
|
$66,680 | — | 01 Mar 2022 | |
| Manher Joshi |
3/4/5
|
EVP, Chief Medical Officer |
—
class O/S missing
|
171,284
|
$66,629 | — | 16 Nov 2023 | |
| Beth C. Seidenberg |
3/4/5
|
Director |
—
mixed-class rows
|
195,386
mixed-class rows
|
$45,080 | — | 31 May 2023 | |
| Joe Newell |
3/4/5
|
Chief Operations Officer |
—
mixed-class rows
|
123,014
mixed-class rows
|
$43,995 | — | 16 Nov 2021 | |
| Roy D. Baynes |
3/4/5
|
Director |
—
mixed-class rows
|
75,000
mixed-class rows
|
$16,922 | — | 23 Jun 2022 | |
| Ronald C. Renaud Jr. |
3/4/5
|
Director |
—
mixed-class rows
|
63,000
mixed-class rows
|
$12,254 | — | 23 Jun 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.02%
|
1,370
|
$11,138 | — | 30 Sep 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.02%
|
1,251
|
$10,171 | — | 30 Sep 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
752
|
$6,114 | — | 30 Sep 2024 | |
| Global Retirement Partners, LLC |
13F
|
Company |
0.01%
|
750
|
$6,098 | — | 30 Sep 2024 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.01%
|
719
|
$5,845 | — | 30 Sep 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.01%
|
644
|
$5,236 | — | 30 Sep 2024 | |
| UBS Group AG |
13F
|
Company |
0%
|
402
|
$3,268 | — | 30 Sep 2024 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
394
|
$3,203 | — | 30 Sep 2024 | |
| IFP Advisors, Inc |
13F
|
Company |
0%
|
180
|
$1,463 | — | 30 Sep 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0%
|
175
|
$1,422 | — | 30 Sep 2024 | |
| LAZARD ASSET MANAGEMENT LLC |
13F
|
Company |
0%
|
129
|
$1,000 | — | 30 Sep 2024 | |
| Catalyst Funds Management Pty Ltd |
13F
|
Company |
0%
|
100
|
$813 | — | 30 Sep 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
56
|
$455 | — | 30 Sep 2024 | |
| GAMMA Investing LLC |
13F
|
Company |
0%
|
56
|
$455 | — | 30 Sep 2024 | |
| EverSource Wealth Advisors, LLC |
13F
|
Company |
0%
|
35
|
$285 | — | 30 Sep 2024 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
8
|
$65 | — | 30 Sep 2024 |
Institutional Holders of Atara Biotherapeutics, Inc. - Common Stock (ATRA) as of Q4 2024
As of 31 Dec 2024,
Atara Biotherapeutics, Inc. - Common Stock (ATRA) was held by
41 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,368,286 shares.
The largest 10 holders included
EcoR1 Capital, LLC, Redmile Group, LLC, CITADEL ADVISORS LLC, BANK OF AMERICA CORP /DE/, VANGUARD GROUP INC, Vestal Point Capital, LP, ACADIAN ASSET MANAGEMENT LLC, TANG CAPITAL MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, and BlackRock, Inc..
This page lists
41
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
33
Q4 2024 holders
41
Holder diff
8
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.